Vanguard Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15M | Sell |
4,089,866
-432,166
| -10% | -$545K | ﹤0.01% | 3208 |
|
|
2025
Q1 | $4.13M | Sell |
4,522,032
-43,413
| -1% | -$39.6K | ﹤0.01% | 3246 |
|
|
2024
Q4 | $7.26M | Sell |
4,565,445
-52,823
| -1% | -$84K | ﹤0.01% | 3114 |
|
|
2024
Q3 | $9.05M | Buy |
4,618,268
+73,562
| +2% | +$144K | ﹤0.01% | 3007 |
|
|
2024
Q2 | $7.45M | Buy |
4,544,706
+433,911
| +11% | +$712K | ﹤0.01% | 3068 |
|
|
2024
Q1 | $21.1M | Buy |
4,110,795
+148,751
| +4% | +$765K | ﹤0.01% | 2570 |
|
|
2023
Q4 | $22.7M | Buy |
3,962,044
+139,893
| +4% | +$802K | ﹤0.01% | 2536 |
|
|
2023
Q3 | $18.3M | Buy |
3,822,151
+1,261,920
| +49% | +$6.03M | ﹤0.01% | 2585 |
|
|
2023
Q2 | $10.9M | Sell |
2,560,231
-45,830
| -2% | -$195K | ﹤0.01% | 2897 |
|
|
2023
Q1 | $13.8M | Buy |
2,606,061
+25,844
| +1% | +$137K | ﹤0.01% | 2768 |
|
|
2022
Q4 | $16.2M | Buy |
2,580,217
+26,789
| +1% | +$168K | ﹤0.01% | 2724 |
|
|
2022
Q3 | $26.9M | Buy |
2,553,428
+561,065
| +28% | +$5.92M | ﹤0.01% | 2499 |
|
|
2022
Q2 | $10.8M | Sell |
1,992,363
-9,191
| -0.5% | -$49.9K | ﹤0.01% | 2952 |
|
|
2022
Q1 | $18.4M | Buy |
2,001,554
+1,087,038
| +119% | +$9.98M | ﹤0.01% | 2824 |
|
|
2021
Q4 | $13.8M | Sell |
914,516
-21,884
| -2% | -$330K | ﹤0.01% | 3050 |
|
|
2021
Q3 | $22.4M | Buy |
+936,400
| New | +$22.4M | ﹤0.01% | 2808 |
|